pSivida Corp. Completes Targeted Enrollment of Phase III Trial of Medidur for Posterior Uveitis

pSivida Corp. (NASDAQ:PSDV; ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, ...